Trials / Enrolling By Invitation
Enrolling By InvitationNCT03800160
Greater China Metabolic and Bariatric Surgery Database
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 50,000 (estimated)
- Sponsor
- Beijing Friendship Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Metabolic surgery, as a recognition treatment option for patients with clinical morbid obesity, is gaining increasing appreciation. In addition to substantial weight loss, emerging studies have highlighted that metabolic surgery can substantially ameliorate obesity-related metabolic diseases, including but not limited to type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, obstructive sleep apnea-hypopnea syndrome (OSAHS) and polycystic ovary syndrome (PCOS)in severely obese patients. However, further investigations with larger sample size and longer observation time still needed to clarity the efficacy and safety of metabolic surgery in Chinese patients with obesity and encouraging future research in this field.
Conditions
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2028-04-01
- Completion
- 2029-04-01
- First posted
- 2019-01-11
- Last updated
- 2024-05-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03800160. Inclusion in this directory is not an endorsement.